CoraLite® Plus 488-conjugated CYP7B1 Recombinant antibody
CYP7B1 Uni-rAbTM Recombinant Antibody for IF/ICC
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
230160H5
Cat no : CL488-82927
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL488-82927 targets CYP7B1 in IF/ICC applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | CYP7B1 fusion protein Ag19374 |
Full Name | cytochrome P450, family 7, subfamily B, polypeptide 1 |
Calculated Molecular Weight | 506 aa, 58 kDa |
Observed Molecular Weight | 50-55 kDa |
GenBank Accession Number | BC136574 |
Gene Symbol | CYP7B1 |
Gene ID (NCBI) | 9420 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
CYP7B1(Cytochrome P450 7B1) is also named as 25-hydroxycholesterol 7-alpha-hydroxylase and belongs to the cytochrome P450 family. It catalyzes the first and rate-limiting step in the coonversion of cholesterol to bile acids and CYP7B1-mediated catalysis may play a role for control of the cellular levels of androgens, not only of estrogens.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 CYP7B1 antibody CL488-82927 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |